Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device
| Registry | NCT00480103, acronym ANECOVA |
|---|---|
| Status | Terminated - INHERENT MODIFICATIONS NEEDED BEFORE PROCEEDING |
| Phase | Phase 3 |
| Study type | Interventional; randomized, parallel, masking: none, screening |
| Sponsor | Instituto Valenciano de Infertilidad, IVI VALENCIA (Other); collaborators: Anecova SA |
| Conditions | Healthy |
| Interventions | in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil (Device) |
| Dates | start 2007-08-01, primary completion 2008-11-01, completion 2008-11-01, first posted 2007-05-30, last updated 2011-03-04 |
| Locations | 1 site in Spain |
Related Papers Related Patents Related Grants Related Experts
All trials for Healthy All trials of in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil
We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.
Sex: All, ages: 18 Years to 36 Years, accepts healthy volunteers
Inclusion Criteria: * Women age below 37 * Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH) * Negative serologic screening for HIV, Hep B and C * No uterine or ovarian alterations found by ultrasound * Normal BMI (19 - 29 kg/m2). Exclusion Criteria: * At least 8 stage MII oocytes are not retrieved * Endometriosis or PCO * Severe male factor in the partner
| Facility | City | Country | Status |
|---|---|---|---|
| Instituto Valenciano de Infertilidad Spain | Valencia | Spain |